<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34509649</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>19</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-0183</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Autoimmunity reviews</Title><ISOAbbreviation>Autoimmun Rev</ISOAbbreviation></Journal><ArticleTitle>Post-COVID syndrome. A case series and comprehensive review.</ArticleTitle><Pagination><StartPage>102947</StartPage><MedlinePgn>102947</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.autrev.2021.102947</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1568-9972(21)00222-6</ELocationID><Abstract><AbstractText>The existence of a variety of symptoms with a duration beyond the acute phase of COVID-19, is referred to as post-COVID syndrome (PCS). We aimed to report a series of patients with PCS attending a Post-COVID Unit and offer a comprehensive review on the topic. Adult patients with previously confirmed SARS-CoV-2 infection and PCS were systematically assessed through a semi-structured and validated survey. Total IgG, IgA and IgM serum antibodies to SARS-CoV-2 were evaluated by an electrochemiluminescence immunoassay. A systematic review of the literature and meta-analysis were conducted, following PRISMA guidelines. Univariate and multivariate methods were used to analyze data. Out of a total of 100 consecutive patients, 53 were women, the median of age was 49&#xa0;years (IQR: 37.8-55.3), the median of post-COVID time after the first symptoms was 219&#xa0;days (IQR: 143-258), and 65 patients were hospitalized during acute COVID-19. Musculoskeletal, digestive (i.e., diarrhea) and neurological symptoms including depression (by Zung scale) were the most frequent observed in PCS patients. A previous hospitalization was not associated with PCS manifestation. Arthralgia and diarrhea persisted in more than 40% of PCS patients. The median of anti-SARS-CoV-2 antibodies was 866.2&#xa0;U/mL (IQR: 238.2-1681). Despite this variability, 98 patients were seropositive. Based on autonomic symptoms (by COMPASS 31) two clusters were obtained with different clinical characteristics. Levels of anti-SARS-CoV-2 antibodies were not different between clusters. A total of 40 articles (11,196 patients) were included in the meta-analysis. Fatigue/muscle weakness, dyspnea, pain and discomfort, anxiety/depression and impaired concentration were presented in more than 20% of patients reported. In conclusion, PCS is mainly characterized by musculoskeletal, pulmonary, digestive and neurological involvement including depression. PCS is independent of severity of acute illness and humoral response. Long-term antibody responses to SARS-CoV-2 infection and a high inter-individual variability were confirmed. Future studies should evaluate the mechanisms by which SARS-CoV-2 may cause PCS and the best therapeutic options.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Anaya</LastName><ForeName>Juan-Manuel</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogot&#xe1;, Colombia; Cl&#xed;nica del Occidente, Bogot&#xe1;, Colombia. Electronic address: juan.anaya@urosario.edu.co.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rojas</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salinas</LastName><ForeName>Martha L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Cl&#xed;nica del Occidente, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez</LastName><ForeName>Yhojan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogot&#xe1;, Colombia; Cl&#xed;nica del Occidente, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roa</LastName><ForeName>Geraldine</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lozano</LastName><ForeName>Marcela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez-Jim&#xe9;nez</LastName><ForeName>M&#xf3;nica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montoya</LastName><ForeName>Norma</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Cl&#xed;nica del Occidente, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zapata</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Post-COVID study group</CollectiveName><AffiliationInfo><Affiliation>School of Medicine and Health Sciences, Universidad del Rosario, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monsalve</LastName><ForeName>Diana M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acosta-Ampudia</LastName><ForeName>Yeny</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ram&#xed;rez-Santana</LastName><ForeName>Carolina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Autoimmun Rev</MedlineTA><NlmUniqueID>101128967</NlmUniqueID><ISSNLinking>1568-9972</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="Y">Antibodies, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post-COVID syndrome</Keyword><Keyword MajorTopicYN="N">Post-acute COVID-19</Keyword><Keyword MajorTopicYN="N">Prolonged COVID</Keyword><Keyword MajorTopicYN="N">anti-Sars-Cov-2 antibodies</Keyword></KeywordList><CoiStatement>None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>12</Day><Hour>20</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34509649</ArticleId><ArticleId IdType="pmc">PMC8428988</ArticleId><ArticleId IdType="doi">10.1016/j.autrev.2021.102947</ArticleId><ArticleId IdType="pii">S1568-9972(21)00222-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Institute for Health and Care Excellence . NICE Guid. 2021. COVID-19 rapid guideline: Managing the long-term effects of COVID-19.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta-Ampudia Y., Monsalve D.M., Rojas M., Rodr&#xed;guez Y., Gallo J.E., Salazar-Uribe J.C., et al. COVID-19 convalescent plasma composition and immunological effects in severe patients. J Autoimmun. 2021;118:102598. doi: 10.1016/j.jaut.2021.102598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2021.102598</ArticleId><ArticleId IdType="pmc">PMC7826092</ArticleId><ArticleId IdType="pubmed">33524876</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W., Ni Z., Hu Y., Liang W., Ou C., He J., et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708&#x2013;1720. doi: 10.1056/NEJMoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon Sandra, Wegman-Ostrosky Talia, Perelman Carol, Sepulveda Rosalinda, Rebolledo Paulina A., Angelica Cuapio S.V. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. MedRxiv. 2021 doi: 10.1101/2021.01.27.21250617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.27.21250617</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal P., Choi J.J., Pinheiro L.C., Schenck E.J., Chen R., Jabri A., et al. Clinical characteristics of Covid-19 in New York City. N Engl J Med. 2020;382:2372&#x2013;2374. doi: 10.1056/NEJMc2010419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2010419</ArticleId><ArticleId IdType="pmc">PMC7182018</ArticleId><ArticleId IdType="pubmed">32302078</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C., Murray B., Varsavsky T., Graham M., Penfold R., Bowyer R., et al. Attributes and predictors of Long-COVID: analysis of COVID cases and their symptoms collected by the Covid Symptoms Study App. BMJ. 2020 doi: 10.1101/2020.10.19.20214494. In press.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.19.20214494</ArticleId></ArticleIdList></Reference><Reference><Citation>Garrigues E., Janvier P., Kherabi Y., Le Bot A., Hamon A., Gouze H., et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81:e4&#x2013;e6. doi: 10.1016/j.jinf.2020.08.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.08.029</ArticleId><ArticleId IdType="pmc">PMC7445491</ArticleId><ArticleId IdType="pubmed">32853602</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Khunti K., Nafilyan V., Maddox T., Humberstone B., Diamond I., et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021:n693. doi: 10.1136/bmj.n693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannis D., Allen S.L., Tsang J., Flint S., Pinhasov T., Williams S., et al. Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry. Blood. 2021;137:2838&#x2013;2847. doi: 10.1182/blood.2020010529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020010529</ArticleId><ArticleId IdType="pmc">PMC8032474</ArticleId><ArticleId IdType="pubmed">33824972</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal M., Abo Omirah M., Hussein A., Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. 2021;75 doi: 10.1111/ijcp.13746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.13746</ArticleId><ArticleId IdType="pmc">PMC7536922</ArticleId><ArticleId IdType="pubmed">32991035</ArticleId></ArticleIdList></Reference><Reference><Citation>Vicente Herrero M.T., Delgado Bueno S., Bandr&#xe9;s Moy&#xe1; F., de la Torre MV Ram&#xed;rez I&#xf1;iguez, Capdevila Garc&#xed;a L. Valoraci&#xf3;n del dolor. Revisi&#xf3;n Comparativa de Escalas y Cuestionarios. Rev Soc Esp Dolor. 2018 doi: 10.20986/resed.2018.3632/2017.</Citation><ArticleIdList><ArticleId IdType="doi">10.20986/resed.2018.3632/2017</ArticleId></ArticleIdList></Reference><Reference><Citation>GeCo Group . Politec Di Milan; Italy: 2020. Towards a cooperative construction of questionnaires for Covid-19 host genetics initiative.</Citation></Reference><Reference><Citation>Guler S.A., Ebner L., Aubry-Beigelman C., Bridevaux P.-O., Brutsche M., Clarenbach C., et al. Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur Respir J. 2021;57 doi: 10.1183/13993003.03690-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03690-2020</ArticleId><ArticleId IdType="pmc">PMC8082329</ArticleId><ArticleId IdType="pubmed">33419891</ArticleId></ArticleIdList></Reference><Reference><Citation>Zung W.W.K. A self-rating depression scale. Arch Gen Psychiatry. 1965;12:63. doi: 10.1001/archpsyc.1965.01720310065008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archpsyc.1965.01720310065008</ArticleId><ArticleId IdType="pubmed">14221692</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli E.T., Schiabor Barrett K.M., Riffle S., Bolze A., Neveux I., Dabe S., et al. Long-term COVID-19 symptoms in a large unselected population. MedRxiv. 2020 doi: 10.1101/2020.10.07.20208702. 2020.10.07.20208702.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.07.20208702</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas M., Rodriguez Y., Pacheco Y., Zapata E., Monsalve D.M., Mantilla R.D., et al. Resilience in women with autoimmune rheumatic diseases. Jt Bone Spine. 2018;85:715&#x2013;720. doi: 10.1016/j.jbspin.2017.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbspin.2017.12.012</ArticleId><ArticleId IdType="pubmed">29289647</ArticleId></ArticleIdList></Reference><Reference><Citation>Campo-Arias A., D&#xed;az-Mart&#xed;nez L.A., Rueda-Jaimes G.E., Barros-Berm&#xfa;dez J.A. Validaci&#xf3;n de la escala de Zung para depresi&#xf3;n en universitarias de Bucaramanga, Colombia. Rev Colomb Psiquiatr. 2005;34:54&#x2013;62.</Citation></Reference><Reference><Citation>Sletten D.M., Suarez G.A., Low P.A., Mandrekar J., Singer W. COMPASS 31: a refined and abbreviated composite autonomic symptom score. Mayo Clin Proc. 2012;87:1196&#x2013;1201. doi: 10.1016/j.mayocp.2012.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2012.10.013</ArticleId><ArticleId IdType="pmc">PMC3541923</ArticleId><ArticleId IdType="pubmed">23218087</ArticleId></ArticleIdList></Reference><Reference><Citation>Page M.J., Moher D., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. doi: 10.1136/bmj.n160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n160</ArticleId><ArticleId IdType="pmc">PMC8005925</ArticleId><ArticleId IdType="pubmed">33781993</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartigan J.A., Wong M.A. Algorithm AS 136: a K-means clustering algorithm. Appl Stat. 1979;28:100. doi: 10.2307/2346830.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2346830</ArticleId></ArticleIdList></Reference><Reference><Citation>Brand&#xe3;o Neto D., Fornazieri M.A., Dib C., Di Francesco R.C., Doty R.L., Voegels R.L., et al. Chemosensory dysfunction in COVID-19: prevalences, recovery rates, and clinical associations on a large Brazilian sample. Otolaryngol Neck Surg. 2021;164:512&#x2013;518. doi: 10.1177/0194599820954825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0194599820954825</ArticleId><ArticleId IdType="pmc">PMC7464054</ArticleId><ArticleId IdType="pubmed">32867582</ArticleId></ArticleIdList></Reference><Reference><Citation>Santis L.V.-D., Sobrino B., Gonz&#xe1;lez G.E., Ru&#xed;z-Mesa J.D., Plata A., M&#xe1;rquez-G&#xf3;mez I., et al. Clinical and immunoserological status 12 weeks after infection with COVID-19: prospective observational study. MedRxiv. 2020 doi: 10.1101/2020.10.06.20206060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.06.20206060</ArticleId></ArticleIdList></Reference><Reference><Citation>Akter F., Mannan A., Mehedi H.M.H., Rob M.A., Ahmed S., Salauddin A., et al. Clinical characteristics and short term outcomes after recovery from COVID-19 in patients with and without diabetes in Bangladesh. Diabetes Metab Syndr Clin Res Rev. 2020;14:2031&#x2013;2038. doi: 10.1016/j.dsx.2020.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.10.016</ArticleId><ArticleId IdType="pmc">PMC7575434</ArticleId><ArticleId IdType="pubmed">33113469</ArticleId></ArticleIdList></Reference><Reference><Citation>Goel N., Goyal N., Kumar R. Clinico-radiological evaluation of post COVID-19 at a tertiary pulmonary care centre in Delhi. India Monaldi Arch Chest Dis. 2021 doi: 10.4081/monaldi.2021.1682.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/monaldi.2021.1682</ArticleId><ArticleId IdType="pubmed">33691394</ArticleId></ArticleIdList></Reference><Reference><Citation>Alemanno F., Houdayer E., Parma A., Spina A., Del Forno A., Scatolini A., et al. COVID-19 cognitive deficits after respiratory assistance in the subacute phase: a COVID-rehabilitation unit experience. PLoS One. 2021;16 doi: 10.1371/journal.pone.0246590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0246590</ArticleId><ArticleId IdType="pmc">PMC7870071</ArticleId><ArticleId IdType="pubmed">33556127</ArticleId></ArticleIdList></Reference><Reference><Citation>Ordinola Navarro A., Cervantes-Bojalil J., Cobos Quevedo O. de J., Avila Mart&#xed;nez A., Hern&#xe1;ndez-Jim&#xe9;nez C.A., P&#xe9;rez &#xc1;lvarez E., et al. Decreased quality of life and spirometric alterations even after mild-moderate COVID-19. Respir Med. 2021;181:106391. doi: 10.1016/j.rmed.2021.106391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2021.106391</ArticleId><ArticleId IdType="pmc">PMC8044599</ArticleId><ArticleId IdType="pubmed">33865161</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Shang Y., Song W., Li Q., Xie H., Xu Q., et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463. doi: 10.1016/j.eclinm.2020.100463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100463</ArticleId><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo M.S., Malsy J., P&#xf6;ttgen J., Seddiq Zai S., Ufer F., Hadjilaou A., et al. Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun. 2020;2 doi: 10.1093/braincomms/fcaa205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa205</ArticleId><ArticleId IdType="pmc">PMC7717144</ArticleId><ArticleId IdType="pubmed">33376990</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallukat G., Hohberger B., Wenzel K., F&#xfc;rst J., Schulze-Rothe S., Wallukat A., et al. Functional autoantibodies against G-protein coupled receptors in patients with persistent long-COVID-19 symptoms. J Transl Autoimmun. 2021;4:100100. doi: 10.1016/j.jtauto.2021.100100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtauto.2021.100100</ArticleId><ArticleId IdType="pmc">PMC8049853</ArticleId><ArticleId IdType="pubmed">33880442</ArticleId></ArticleIdList></Reference><Reference><Citation>Skala M., Svoboda M., Kopecky M., Kocova E., Hyrsl M., Homolac M., et al. Heterogeneity of post-COVID impairment: interim analysis of a prospective study from Czechia. Virol J. 2021;18:73. doi: 10.1186/s12985-021-01546-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-021-01546-8</ArticleId><ArticleId IdType="pmc">PMC8040356</ArticleId><ArticleId IdType="pubmed">33845839</ArticleId></ArticleIdList></Reference><Reference><Citation>Osikomaiya B., Erinoso O., Wright K.O., Odusola A.O., Thomas B., Adeyemi O., et al. &#x2018;Long COVID&#x2019;: persistent COVID-19 symptoms in survivors managed in Lagos State. Nigeria BMC Infect Dis. 2021;21:304. doi: 10.1186/s12879-020-05716-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-05716-x</ArticleId><ArticleId IdType="pmc">PMC7993075</ArticleId><ArticleId IdType="pubmed">33765941</ArticleId></ArticleIdList></Reference><Reference><Citation>Arjmand P., Murtaza F., Eshtiaghi A., Popovic M.M., Kertes P.J., Eng K.T. Impact of the COVID-19 pandemic on characteristics of retinal detachments: the Canadian experience. Can J Ophthalmol. 2021;56:88&#x2013;95. doi: 10.1016/j.jcjo.2020.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcjo.2020.12.008</ArticleId><ArticleId IdType="pmc">PMC7832047</ArticleId><ArticleId IdType="pubmed">33444561</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham E., Newcombe V., Michell A., Thornton R., Grainger A., Anwar F., et al. Mononeuritis multiplex: an unexpectedly frequent feature of severe COVID-19. J Neurol. 2020 doi: 10.1007/s00415-020-10321-8. In press.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10321-8</ArticleId><ArticleId IdType="pmc">PMC7690651</ArticleId><ArticleId IdType="pubmed">33244712</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A., Wamil M., Alberts J., Oben J., Cuthbertson D.J., Wootton D., et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ. 2021;11 doi: 10.1136/bmjopen-2020-048391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C., Rodr&#xed;guez-Jim&#xe9;nez J., Fuensalida-Novo S., Palacios-Ce&#xf1;a M., G&#xf3;mez-Mayordomo V., Florencio L.L., et al. Myalgia as a symptom at hospital admission by severe acute respiratory syndrome coronavirus 2 infection is associated with persistent musculoskeletal pain as long-term post-COVID sequelae. Pain. 2021 doi: 10.1097/j.pain.0000000000002306. In press.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002306</ArticleId><ArticleId IdType="pubmed">33863864</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambini G., Savastano M.C., Savastano A., De Vico U., Crincoli E., Cozzupoli G.M., et al. Ocular surface impairment after coronavirus disease 2019: a cohort study. Cornea. 2021;40:477&#x2013;483. doi: 10.1097/ICO.0000000000002643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ICO.0000000000002643</ArticleId><ArticleId IdType="pubmed">33214412</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein H., Asseo K., Karni N., Benjamini Y., Nir-Paz R., Muszkat M., et al. Onset, duration and unresolved symptoms, including smell and taste changes, in mild COVID-19 infection: a cohort study in Israeli patients. Clin Microbiol Infect. 2021;27:769&#x2013;774. doi: 10.1016/j.cmi.2021.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.02.008</ArticleId><ArticleId IdType="pmc">PMC7884919</ArticleId><ArticleId IdType="pubmed">33607252</ArticleId></ArticleIdList></Reference><Reference><Citation>Leta V., Rodr&#xed;guez-Violante M., Abundes A., Rukavina K., Teo J.T., Falup-Pecurariu C., et al. Parkinson&#x2019;s disease and post&#x2013;COVID-19 Syndrome: the Parkinson&#x2019;s long-COVID spectrum. Mov Disord. 2021 doi: 10.1002/mds.28622. mds.28622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28622</ArticleId><ArticleId IdType="pmc">PMC8250675</ArticleId><ArticleId IdType="pubmed">33890344</ArticleId></ArticleIdList></Reference><Reference><Citation>Savastano A., Crincoli E., Savastano M., Younis S., Gambini G., De Vico U., et al. Peripapillary retinal vascular involvement in early post-COVID-19 patients. J Clin Med. 2020;9:2895. doi: 10.3390/jcm9092895.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9092895</ArticleId><ArticleId IdType="pmc">PMC7565672</ArticleId><ArticleId IdType="pubmed">32911619</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., Dunne J., Mooney A., Gaffney F., et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020;15 doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaber T.A.-Z.K., Ashish A., Unsworth A. Persistent post-covid symptoms in healthcare workers. Occup Med (Chic Ill) 2021 doi: 10.1093/occmed/kqab043. In press.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/occmed/kqab043</ArticleId><ArticleId IdType="pmc">PMC8083525</ArticleId><ArticleId IdType="pubmed">33830208</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S., Barnett J., Brill S.E., Brown J.S., Denneny E.K., Hare S.S., et al. &#x2018;Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76:396&#x2013;398. doi: 10.1136/thoraxjnl-2020-215818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K., Ghanima W., Olsen M.K., Gilboe H.M., Einvik G. Persistent symptoms 1.5&#x2013;6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax. 2021;76:405&#x2013;407. doi: 10.1136/thoraxjnl-2020-216377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216377</ArticleId><ArticleId IdType="pmc">PMC7716295</ArticleId><ArticleId IdType="pubmed">33273028</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz Y.M.J., Van Herck M., Delbressine J.M., Vaes A.W., Meys R., Machado F.V.C., et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6:00542&#x2013;02020. doi: 10.1183/23120541.00542-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Leth S., Gunst J.D., Mathiasen V., Hansen K., S&#xf8;gaard O., &#xd8;stergaard L., et al. Persistent symptoms in patients recovering from COVID-19 in Denmark. Open Forum Infect Dis. 2021;8 doi: 10.1093/ofid/ofab042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab042</ArticleId><ArticleId IdType="pmc">PMC7928683</ArticleId><ArticleId IdType="pubmed">33875970</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes D.L., Holdsworth L., Jawad N., Gunasekera P., Morice A.H., Crooks M.G. Post-COVID-19 symptom burden: what is long-COVID and how should we manage it? Lung. 2021;199:113&#x2013;119. doi: 10.1007/s00408-021-00423-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00408-021-00423-z</ArticleId><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmud R., Rahman M.M., Rassel M.A., Monayem F.B., Sayeed S.K.J.B., Islam M.S., et al. Post-COVID-19 syndrome among symptomatic COVID-19 patients: a prospective cohort study in a tertiary care center of Bangladesh. PLoS One. 2021;16 doi: 10.1371/journal.pone.0249644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0249644</ArticleId><ArticleId IdType="pmc">PMC8031743</ArticleId><ArticleId IdType="pubmed">33831043</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin S.J., McIvor C., Whyatt G., Adams A., Harvey O., McLean L., et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2021;93:1013&#x2013;1022. doi: 10.1002/jmv.26368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26368</ArticleId><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Simani L., Ramezani M., Darazam I.A., Sagharichi M., Aalipour M.A., Ghorbani F., et al. Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19. J Neurovirol. 2021;27:154&#x2013;159. doi: 10.1007/s13365-021-00949-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-021-00949-1</ArticleId><ArticleId IdType="pmc">PMC7852482</ArticleId><ArticleId IdType="pubmed">33528827</ArticleId></ArticleIdList></Reference><Reference><Citation>Savastano M.C., Gambini G., Cozzupoli G.M., Crincoli E., Savastano A., De Vico U., et al. Retinal capillary involvement in early post-COVID-19 patients: a healthy controlled study. Graefes Arch Clin Exp Ophthalmol. 2021 doi: 10.1007/s00417-020-05070-3. In press.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00417-020-05070-3</ArticleId><ArticleId IdType="pmc">PMC7848665</ArticleId><ArticleId IdType="pubmed">33523252</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqbal A., Iqbal K., Arshad Ali S., Azim D., Farid E., Baig M.D., et al. The COVID-19 sequelae: a cross-sectional evaluation of post-recovery symptoms and the need for rehabilitation of COVID-19 survivors. Cureus. 2021 doi: 10.7759/cureus.13080. In press.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.13080</ArticleId><ArticleId IdType="pmc">PMC7932827</ArticleId><ArticleId IdType="pubmed">33680620</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam M.S., Ferdous M.Z., Islam U.S., Mosaddek A.S.M., Potenza M.N., Pardhan S. Treatment, persistent symptoms, and depression in people infected with COVID-19 in Bangladesh. Int J Environ Res Public Health. 2021;18:1453. doi: 10.3390/ijerph18041453.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18041453</ArticleId><ArticleId IdType="pmc">PMC7914967</ArticleId><ArticleId IdType="pubmed">33562427</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X., Liu X., Zhou Y., Yu H., Li R., Zhan Q., et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med. 2021 doi: 10.1016/S2213-2600(21)00174-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00174-0</ArticleId><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallus R., Melis A., Rizzo D., Piras A., De Luca L.M., Tramaloni P., et al. Audiovestibular symptoms and sequelae in COVID-19 patients. J Vestib Res. 2021:1&#x2013;7. doi: 10.3233/VES-201505. In press.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/VES-201505</ArticleId><ArticleId IdType="pubmed">33579886</ArticleId></ArticleIdList></Reference><Reference><Citation>Shouman K., Vanichkachorn G., Cheshire W.P., Suarez M.D., Shelly S., Lamotte G.J., et al. Autonomic dysfunction following COVID-19 infection: an early experience. Clin Auton Res. 2021 doi: 10.1007/s10286-021-00803-8. In press.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-021-00803-8</ArticleId><ArticleId IdType="pmc">PMC8050227</ArticleId><ArticleId IdType="pubmed">33860871</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Zhao P., Tang D., Zhu T., Han R., Zhan C., et al. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc Imaging. 2020;13:2330&#x2013;2339. doi: 10.1016/j.jcmg.2020.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.05.004</ArticleId><ArticleId IdType="pmc">PMC7214335</ArticleId><ArticleId IdType="pubmed">32763118</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T., Sahanic S., Pizzini A., Luger A., Schwabl C., Sonnweber B., et al. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J. 2021;57:2003481. doi: 10.1183/13993003.03481-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03481-2020</ArticleId><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok F.A., Kruip M.J.H.A., van der Meer N.J.M., Arbous M.S., Gommers D.A.M.P.J., Kant K.M., et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145&#x2013;147. doi: 10.1016/j.thromres.2020.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.04.013</ArticleId><ArticleId IdType="pmc">PMC7146714</ArticleId><ArticleId IdType="pubmed">32291094</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraussen J., Marquez S., Takata K., Beckers L., Montes Diaz G., Zografou C., et al. Phenotypic and Ig repertoire analyses indicate a common origin of IgD &#x2212; CD27 &#x2212; double negative B cells in healthy individuals and multiple sclerosis patients. J Immunol. 2019;203:1650&#x2013;1664. doi: 10.4049/jimmunol.1801236.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1801236</ArticleId><ArticleId IdType="pmc">PMC6736705</ArticleId><ArticleId IdType="pubmed">31391234</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuwa H.A., Shaw T.N., Knight S.B., Wemyss K., McClure F.A., Pearmain L., et al. Alterations in T and B cell function persist in convalescent COVID-19 patients. Med. 2021 doi: 10.1016/j.medj.2021.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2021.03.013</ArticleId><ArticleId IdType="pmc">PMC8011689</ArticleId><ArticleId IdType="pubmed">33821250</ArticleId></ArticleIdList></Reference><Reference><Citation>Talla A., Vasaikar S.V., Lemos M.P., Moodie Z., Pebworth M.-P.L., Henderson K.E., et al. Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence. BioRxiv. 2021 doi: 10.1101/2021.05.26.442666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.26.442666</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong S.W.X., Fong S.-W., Young B.E., Chan Y.-H., Lee B., Amrun S.N., et al. Persistent symptoms and association with inflammatory cytokine signatures in recovered coronavirus disease 2019 patients. Open Forum Infect Dis. 2021:8. doi: 10.1093/ofid/ofab156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab156</ArticleId><ArticleId IdType="pmc">PMC8083585</ArticleId><ArticleId IdType="pubmed">34095336</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez Y., Rojas M., Ram&#xed;rez-Santana C., Acosta-Ampudia Y., Monsalve D.M., Anaya J.-M. Autonomic symptoms following Zika virus infection. Clin Auton Res. 2018;28:211&#x2013;214. doi: 10.1007/s10286-018-0515-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-018-0515-1</ArticleId><ArticleId IdType="pubmed">29497887</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O., Merino E., Leon-Ramirez J.-M., Andres M., Ramos J.M., Arenas-Jim&#xe9;nez J., et al. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect. 2021;82:378&#x2013;383. doi: 10.1016/j.jinf.2021.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold D.T., Hamilton F.W., Milne A., Morley A.J., Viner J., Attwood M., et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2020;76:399&#x2013;401. doi: 10.1136/thoraxjnl-2020-216086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216086</ArticleId><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Persistent SYMPTOMS in patients after acute COVID-19. JAMA. 2020;324:603. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs L.G., Gourna Paleoudis E., Lesky-Di Bari D., Nyirenda T., Friedman T., Gupta A., et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS One. 2020;15 doi: 10.1371/journal.pone.0243882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0243882</ArticleId><ArticleId IdType="pmc">PMC7732078</ArticleId><ArticleId IdType="pubmed">33306721</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemp H.I., Corner E., Colvin L.A. Chronic pain after COVID-19: implications for rehabilitation. Br J Anaesth. 2020;125:436&#x2013;440. doi: 10.1016/j.bja.2020.05.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2020.05.021</ArticleId><ArticleId IdType="pmc">PMC7261464</ArticleId><ArticleId IdType="pubmed">32560913</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulchandani R., Lyngdoh T., Kakkar A.K. Deciphering the COVID-19 cytokine storm: systematic review and meta-analysis. Eur J Clin Invest. 2021;51 doi: 10.1111/eci.13429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13429</ArticleId><ArticleId IdType="pmc">PMC7646004</ArticleId><ArticleId IdType="pubmed">33058143</ArticleId></ArticleIdList></Reference><Reference><Citation>Coomes E.A., Haghbayan H. Interleukin-6 in Covid-19: a systematic review and meta-analysis. Rev Med Virol. 2020;30:1&#x2013;9. doi: 10.1002/rmv.2141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2141</ArticleId><ArticleId IdType="pmc">PMC7460877</ArticleId><ArticleId IdType="pubmed">32845568</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiers S., Ray P.R., Wangzhou A., Sankaranarayanan I., Tatsui C.E., Rhines L.D., et al. ACE2 and SCARF expression in human dorsal root ganglion nociceptors: implications for SARS-CoV-2 virus neurological effects. Pain. 2020;161:2494&#x2013;2501. doi: 10.1097/j.pain.0000000000002051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002051</ArticleId><ArticleId IdType="pmc">PMC7572821</ArticleId><ArticleId IdType="pubmed">32826754</ArticleId></ArticleIdList></Reference><Reference><Citation>McFarland A.J., Yousuf M.S., Shiers S., Price T.J. Neurobiology of SARS-CoV-2 interactions with the peripheral nervous system: implications for COVID-19 and pain. PAIN Reports. 2021;6 doi: 10.1097/PR9.0000000000000885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PR9.0000000000000885</ArticleId><ArticleId IdType="pmc">PMC7803673</ArticleId><ArticleId IdType="pubmed">33458558</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen S.P., Baber Z.B., Buvanendran A., McLean B.C., Chen Y., Hooten W.M., et al. Pain management best practices from multispecialty organizations during the COVID-19 pandemic and public health crises. Pain Med. 2020;21:1331&#x2013;1346. doi: 10.1093/pm/pnaa127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pm/pnaa127</ArticleId><ArticleId IdType="pmc">PMC7184417</ArticleId><ArticleId IdType="pubmed">32259247</ArticleId></ArticleIdList></Reference><Reference><Citation>Sher L. Post-COVID syndrome and suicide risk. QJM. 2021;114:95&#x2013;98. doi: 10.1093/qjmed/hcab007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcab007</ArticleId><ArticleId IdType="pmc">PMC7928695</ArticleId><ArticleId IdType="pubmed">33486531</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S., Whitelaw S. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunol Res. 2021;69:205&#x2013;211. doi: 10.1007/s12026-021-09185-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-021-09185-5</ArticleId><ArticleId IdType="pmc">PMC8009458</ArticleId><ArticleId IdType="pubmed">33786700</ArticleId></ArticleIdList></Reference><Reference><Citation>Thieben M.J., Sandroni P., Sletten D.M., Benrud-Larson L.M., Fealey R.D., Vernino S., et al. Postural orthostatic tachycardia syndrome: the Mayo clinic experience. Mayo Clin Proc. 2007;82:308&#x2013;313. doi: 10.4065/82.3.308.</Citation><ArticleIdList><ArticleId IdType="doi">10.4065/82.3.308</ArticleId><ArticleId IdType="pubmed">17352367</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P. Post COVID-19 syndrome associated with orthostatic cerebral hypoperfusion syndrome, small fiber neuropathy and benefit of immunotherapy: a case report. ENeurologicalSci. 2020;21:100276. doi: 10.1016/j.ensci.2020.100276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ensci.2020.100276</ArticleId><ArticleId IdType="pmc">PMC7502253</ArticleId><ArticleId IdType="pubmed">32984564</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M., Dirksen A., Taraborrelli P., Torocastro M., Panagopoulos D., Sutton R., et al. Autonomic dysfunction in &#x201c;long COVID&#x201d;: rationale, physiology and management strategies. Clin Med (Northfield IL) 2021;21:e63&#x2013;e67. doi: 10.7861/clinmed.2020-0896.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>Miglis M.G., Prieto T., Shaik R., Muppidi S., Sinn D.-I., Jaradeh S. A case report of postural tachycardia syndrome after COVID-19. Clin Auton Res. 2020;30:449&#x2013;451. doi: 10.1007/s10286-020-00727-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-020-00727-9</ArticleId><ArticleId IdType="pmc">PMC7471493</ArticleId><ArticleId IdType="pubmed">32880754</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanjwal K., Jamal S., Kichloo A., Grubb B.P. New-onset postural orthostatic tachycardia syndrome following coronavirus disease 2019 infection. J Innov Card Rhythm Manag. 2020;11:4302&#x2013;4304. doi: 10.19102/icrm.2020.111102.</Citation><ArticleIdList><ArticleId IdType="doi">10.19102/icrm.2020.111102</ArticleId><ArticleId IdType="pmc">PMC7685310</ArticleId><ArticleId IdType="pubmed">33262898</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S. Autoimmune markers and autoimmune disorders in patients with postural tachycardia syndrome (POTS) Lupus. 2015;24:1364&#x2013;1369. doi: 10.1177/0961203315587566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203315587566</ArticleId><ArticleId IdType="pubmed">26038344</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X., Li H., Murphy T.A., Nuss Z., Liles J., Liles C., et al. Angiotensin II Type 1 receptor autoantibodies in postural tachycardia syndrome. J Am Heart Assoc. 2018;7 doi: 10.1161/JAHA.117.008351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.117.008351</ArticleId><ArticleId IdType="pmc">PMC6015435</ArticleId><ArticleId IdType="pubmed">29618472</ArticleId></ArticleIdList></Reference><Reference><Citation>Watari M., Nakane S., Mukaino A., Nakajima M., Mori Y., Maeda Y., et al. Autoimmune postural orthostatic tachycardia syndrome. Ann Clin Transl Neurol. 2018;5:486&#x2013;492. doi: 10.1002/acn3.524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.524</ArticleId><ArticleId IdType="pmc">PMC5899914</ArticleId><ArticleId IdType="pubmed">29687025</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Yu X., Liles C., Khan M., Vanderlinde-Wood M., Galloway A., et al. Autoimmune basis for postural tachycardia syndrome. J Am Heart Assoc. 2014;3 doi: 10.1161/JAHA.113.000755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.113.000755</ArticleId><ArticleId IdType="pmc">PMC3959717</ArticleId><ArticleId IdType="pubmed">24572257</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo X., Jian W., Su Z., Chen M., Peng H., Peng P., et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020;55 doi: 10.1183/13993003.01217-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01217-2020</ArticleId><ArticleId IdType="pmc">PMC7236826</ArticleId><ArticleId IdType="pubmed">32381497</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin W., Chen S., Zhang Y., Dong F., Zhang Z., Hu B., et al. Diffusion capacity abnormalities for carbon monoxide in patients with COVID-19 at three-month follow-up. Eur Respir J. 2021 doi: 10.1183/13993003.03677-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03677-2020</ArticleId><ArticleId IdType="pmc">PMC7877322</ArticleId><ArticleId IdType="pubmed">33574077</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah A.S., Wong A.W., Hague C.J., Murphy D.T., Johnston J.C., Ryerson C.J., et al. A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations. Thorax. 2020;76:402&#x2013;404. doi: 10.1136/thoraxjnl-2020-216308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216308</ArticleId><ArticleId IdType="pubmed">33273023</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel B.V., Arachchillage D.J., Ridge C.A., Bianchi P., Doyle J.F., Garfield B., et al. Pulmonary angiopathy in severe COVID-19: physiologic, imaging, and hematologic observations. Am J Respir Crit Care Med. 2020;202:690&#x2013;699. doi: 10.1164/rccm.202004-1412OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202004-1412OC</ArticleId><ArticleId IdType="pmc">PMC7462405</ArticleId><ArticleId IdType="pubmed">32667207</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanidziar D., Robson S.C. Hyperoxia and modulation of pulmonary vascular and immune responses in COVID-19. Am J Physiol Lung Cell Mol Physiol. 2021;320:L12&#x2013;L16. doi: 10.1152/ajplung.00304.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00304.2020</ArticleId><ArticleId IdType="pmc">PMC7816427</ArticleId><ArticleId IdType="pubmed">33050737</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H., Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37. doi: 10.1186/1471-2377-11-37.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-11-37</ArticleId><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui D.S. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax. 2005;60:401&#x2013;409. doi: 10.1136/thx.2004.030205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2004.030205</ArticleId><ArticleId IdType="pmc">PMC1758905</ArticleId><ArticleId IdType="pubmed">15860716</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui D.S., Wong K.T., Ko F.W., Tam L.S., Chan D.P., Woo J., et al. The 1-year impact of severe acute respiratory syndrome on pulmonary function, exercise capacity, and quality of life in a cohort of survivors. Chest. 2005;128:2247&#x2013;2261. doi: 10.1378/chest.128.4.2247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.128.4.2247</ArticleId><ArticleId IdType="pmc">PMC7094276</ArticleId><ArticleId IdType="pubmed">16236881</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M., Schommers P., Stecher M., Dewald F., Gieselmann L., Gruell H., et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Heal Eur. 2021;6:100122. doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosey M.M., Needham D.M. Survivorship after COVID-19 ICU stay. Nat Rev Dis Primers. 2020;6:60. doi: 10.1038/s41572-020-0201-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-020-0201-1</ArticleId><ArticleId IdType="pmc">PMC7362322</ArticleId><ArticleId IdType="pubmed">32669623</ArticleId></ArticleIdList></Reference><Reference><Citation>Okba N.M.A., M&#xfc;ller M.A., Li W., Wang C., GeurtsvanKessel C.H., Corman V.M., et al. Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease patients. Emerg Infect Dis. 2020;26:1478&#x2013;1488. doi: 10.3201/eid2607.200841.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2607.200841</ArticleId><ArticleId IdType="pmc">PMC7323511</ArticleId><ArticleId IdType="pubmed">32267220</ArticleId></ArticleIdList></Reference><Reference><Citation>Dan J.M., Mateus J., Kato Y., Hastie K.M., Yu E.D., Faliti C.E., et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science (80-) 2021;371 doi: 10.1126/science.abf4063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abf4063</ArticleId><ArticleId IdType="pmc">PMC7919858</ArticleId><ArticleId IdType="pubmed">33408181</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzoni A., Maggi L., Capone M., Vanni A., Spinicci M., Salvati L., et al. Heterogeneous magnitude of immunological memory to SARS-CoV-2 in recovered individuals. Clin Transl Immunol. 2021;10 doi: 10.1002/cti2.1281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cti2.1281</ArticleId><ArticleId IdType="pmc">PMC8101693</ArticleId><ArticleId IdType="pubmed">33976879</ArticleId></ArticleIdList></Reference><Reference><Citation>Folgueira M.D., Luczkowiak J., Lasala F., P&#xe9;rez-Rivilla A., Delgado R. Prolonged SARS-CoV-2 cell culture replication in respiratory samples from patients with severe COVID-19. Clin Microbiol Infect. 2021;27:886&#x2013;891. doi: 10.1016/j.cmi.2021.02.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.02.014</ArticleId><ArticleId IdType="pmc">PMC7898982</ArticleId><ArticleId IdType="pubmed">33631334</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamanna F., Veronesi F., Martini L., Landini M.P., Fini M. Post-COVID-19 syndrome: the persistent symptoms at the post-viral stage of the disease. A systematic review of the current data. Front Med. 2021;8:653516. doi: 10.3389/fmed.2021.653516.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.653516</ArticleId><ArticleId IdType="pmc">PMC8129035</ArticleId><ArticleId IdType="pubmed">34017846</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>